Makers of the sam® wearable ultrasound unit demonstrate how its devices promote injury healing and complement orthopedic surgery procedures.
Creators of sustained acoustic medicine technology will instruct orthopedic surgeons, sports medicine physicians, physical therapists, and other practitioners in using the sam® X1 ultrasound treatment device.
Presentations at long-running, prestigious meeting will focus on effectiveness of sustained acoustic medicine in soft tissue healing.
Clinical education director Dr. Rajiv Mallipudi will present on sam® research and treatment protocols in a program for members of The Orthobiologic Institute.
Sustained acoustic medicine delivered by wearable ultrasound device and topical diclofenac patch reduced patients' pain and improved clinical outcomes beyond traditional patient care.
Displayed the advantages of the sam X1 device as a faster way for patients to repair and recover from soft-tissue injuries before returning to work or play.
Studies show hamstring and UCL injuries are most common in opening weeks, and sustained acoustic medicine is effective treatment for those soft-tissue injuries.
Clinical investigator and regenerative medicine pioneer Don Buford, MD, is leading the charge to bring the latest advances in mechanobiology and regenerative medicine to 32.5 million knee arthritis sufferers across the United States in a National Institutes of Health-funded study aimed at reducing opioids and surgery.
Sustained acoustic medicine brings relief to professional and collegiate tennis players by promoting soft tissue healing.
The Interventional Orthobiologics Foundation Conference is one of the largest gatherings of orthopedic and interventional pain specialists in the United States with a focus on innovation
The conference provides continuing education and facilitates communication among interested sports medicine professionals.
Creator of wearable sustained acoustic medicine technology to educate clinicians on device's effectiveness in soft tissue healing and regenerative medicine treatment.
The sam®x1 is an effective tool for treating acute musculoskeletal injuries and the first wireless long-duration ultrasound system that is FDA-cleared for prescription home use.
The Ambassador Program seeks athletic trainers and social media influencers, amateurs and professionals alike, to promote the proven real-world benefits of sustained acoustic medicine.
The device's ease of use permits players to wear sam® for long periods discreetly, allowing athletes to attend class while maintaining 100% treatment compliance during recovery.
The lunch and lecture provided scientific updates on sustained acoustic medicine research in sports medicine, significant product innovations, and the new 2023 Player Performance Package (PPP).
The sam®x1 wireless sustained acoustic medicine device helps sports and regenerative medicine providers return their patients to everyday activities.
The specialized ultrasound treatment is now available to medical professionals across the United States.
Board-certified physicians use the ZetrOZ Systems sustained acoustic medicine device for injury healing and pain relief without invasive surgery or potentially addictive and dangerous medications.
First-year graduate students at Merrimack College taking Therapeutic Modalities will learn about the effects and benefits of long-duration, sustained acoustic medicine (sam®) on soft-tissue healing.
ZetrOZ's sam®️ technology promotes soft tissue healing, helping patients return to work sooner and preventing more severe injuries; the only FDA-cleared home-use multi-hour ultrasound stimulator.
ZetrOZ Systems will showcase its sustained acoustic medicine (sam®) technology, a non-invasive, non-systemic treatment option for soft-tissue injuries experienced in the workplace and beyond. The companies' partnerships with self-insured and insurance providers has expanded access to millions of lives in America.
The wireless, long-duration, continuous, ultrasound, patch-based stimulator delivers 33 times more treatment than pulsed ultrasound devices and is authorized by the FDA for prescription home use in the United States of America.
A sam® regimen prioritizes healing beyond the pain to emphasize the importance of returning patients fully back to health to minimize the risk of chronic, recurring injuries.
New clinical research sheds light on the use of sam®, a medical ultrasound device for prescription home use, for pain mitigation in soft tissue injuries.
At a recent conference of professional hockey trainers, ZetrOZ Systems, a leading innovator and inventor of sustained acoustic medicine (sam®) for soft tissue injury healing, presented results of studies indicating the medical device is highly effective at treating the types of injuries hockey players frequently experience.
sam® by Zetroz Systems utilizes high-frequency, low-intensity continuous ultrasound to facilitate the healing of injured musculoskeletal tissue in the home of the patient.
Effective management of a company's intellectual property can create significant advantages, crucial in today's competitive health technology marketplace.
Creator of sustained acoustic medicine soft tissue healing device reports that even FDA-cleared devices backed by body of research and millions of successful treatments still face hurdles.
Innovative medical technologies like the sam® device promote soft tissue healing
The FDA-cleared home-use ultrasound device will be featured at the world's largest gathering of orthopaedic surgeons
New research shows SAM medical technology can deliver nonsteroidal, anti-inflammatory drugs (NSAIDs) locally and more effectively than existing technologies in the treatment of arthritis.
The sustained acoustic medicine treatment reduces the cause of pain, accelerates the healing process, delivers mechanical compression, increases deep circulation, enhances oxygen and nutrient delivery and provides daily therapy multiple hours per day. The technology is proven in over 20 clinical trials supporting the efficacy of treatment.